|
Press Releases |
|
|
|
Friday, September 23, 2022 |
|
Malaysian Genomics Grows Presence in Thailand |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
Wednesday, September 21, 2022 |
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
Tuesday, August 30, 2022 |
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
Monday, August 29, 2022 |
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. more info >> |
|
Thursday, August 18, 2022 |
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
Wednesday, July 20, 2022 |
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
Friday, July 15, 2022 |
|
Malaysian Genomics Appoints New Chairman |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
Wednesday, July 13, 2022 |
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
Friday, July 8, 2022 |
|
Malaysian Genomics Proposes Private Placement |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
Wednesday, July 6, 2022 |
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
特步宣布战略性出售K-Swiss及帕拉丁 并优化财务结构
May 9, 2024 20:28 HKT/SGT
|
|
|
特步宣佈戰略性出售K-Swiss及帕拉丁 並優化財務結構
May 9, 2024 20:25 HKT/SGT
|
|
|
Xtep Announces Strategic Divestiture of K-Swiss and Palladium and Enhanced Financial Structure
May 9, 2024 20:18 HKT/SGT
|
|
|
Paltalk, Inc. Reports Slight Increase in Revenue and 33% Reduction in Net Loss for First Quarter 2024
May 9, 2024 20:39 JST
|
|
|
ソニー独自のマイクロサージャリー支援ロボットを開発
May 9, 2024 18:00: JST
|
|
|
Honda、インドでの電動化の加速に向けた研究開発拠点をベンガルールに開設
May 9, 2024 13:50: JST
|
|
|
LEXUS、「LM」に6座仕様車を追加設定
May 9, 2024 13:45: JST
|
|
|
富士通、がんのタイプ分けなどのゲノム医療分野の課題を世界最高精度で解く、説明可能なAI技術を開発
May 9, 2024 13:30: JST
|
|
|
Honda Opens New R&D Facility in Bengaluru to Accelerate Electrification in India
May 9, 2024 14:13 JST
|
|
|
Malaysian Retail Sector Sees a 173% Growth in Hiring: foundit Insights Tracker
May 9, 2024 12:00 HKT/SGT
|
|
|
Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning
May 9, 2024 10:41 JST
|
|
|
Solar & Storage Live Philippines Leading Sustainability And Innovation In The Philippines Energy Sector
May 9, 2024 08:19 HKT/SGT
|
|
|
Saakuru and Blockpass Partner for Compliance in the Best Economic Opportunities Web3 Offers
May 9, 2024 08:00 HKT/SGT
|
|
|
Avance Clinical, 한국에서 새로운 임상 운영으로 APAC 지역으로 더 확장
May 9, 2024 08:00 HKT/SGT
|
|
|
SMC Announces LOI to Acquire Chaintrade LTD.
May 9, 2024 07:59 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|